Award

Gierasch lauded as ‘rigorous biophysical chemist’ and ‘phenomenal mentor’

Anna Shipman
By Anna Shipman
March 1, 2014

The American Society of Biochemistry and Molecular Biology has awarded Lila Gierasch the 2014 Mildred Cohn Award in Biological Chemistry for her extensive work in protein folding, structure and function. This award recognizes scientists who have made substantial advances in the field of biological chemistry through the use of innovative physical methods.

Gierasch’s early research into the relationship between amino-acid sequence and peptide and protein structure resulted in the development of fundamental principles for reverse-turn conformation features as well as the establishment of several biophysical methods commonly used today to characterize protein turns, such as nuclear magnetic resonance, quantitative nuclear Overhauser effects, circular dichroism and computational modeling. This research was also the basis for Gierasch’s later research using peptide fragments to examine protein recognition motifs. A major focus in Gierasch's lab has been how protein folding occurs within the cell, using transferred nuclear Overhauser effect, or trNOE, methods to show how chaperone proteins recognize the folded state of a protein substrate.

Lila GieraschI am thrilled to be chosen to receive the Mildred Cohn Award from ASBMB. She was one of my heroes; her contributions reflect her deep physical understanding, her experimental boldness and her willingness to deploy any biophysical approach that would answer the key questions underlying a biological system.

My laboratory’s contributions reflect the energy, creativity, enthusiasm, hard work and dedication of the wonderful students and postdocs I have worked with through the years. I thank them! In addition, thanks to many collaborators who worked with us to tackle daunting problems, who elevated our science and who shared the pleasures of garnering meaningful results. 
—LILA GIERASCH 

 

“Lila is a rigorous biophysical chemist, but unlike most chemists who avoid complexity and prefer reductionist type studies, Lila’s whole career has been focused on applying chemistry and biophysical methods to the study of peptides and their role in biology as well as protein folding and trafficking in vivo,” says Jeffrey W. Kelly at The Scripps Research Institute. “Her work is insightful, revealing and is well ahead of its time.”
 

Some of Gierasch’s more recent work has been focused on developing and testing experimentally a computational model of cellular protein homeostasis in E. coli in collaboration with Evan Powers of The Scripps Institute. This collaboration has resulted in FoldEco, an online modeling program used to examine how protein folding in the cell is facilitated by chaperone and degradation networks. Gierasch’s lab also uses fluorescent reporters to study how protein sequence may affect protein aggregation and folding.

Gierasch earned her A.B. in chemistry in 1970 from Mount Holyoke College in South Hadley, Mass., and earned a Ph.D in biophysics from Harvard University in Cambridge, Mass., from the lab of Elkan R. Blout in 1975.
 

Today Gierasch is a distinguished professor at the University of Massachusetts Amherst. She has mentored many undergraduate and graduate students and postdoctoral fellows; served on many editorial advisory boards; and played leadership roles in several scientific societies.

“To me, Lila is not only an outstanding scientist who has made milestone and unique contributions to her own research field but also a phenomenal mentor who never ceases to inspire and help many of her mentees to launch success in their careers,” says Ning Zheng, Professor at University of Washington and an Howard Hughes Medical Institute Investigator. “Her achievements as a scholar, a leader and a mentor are extraordinary at every level.”

Gierasch will receive the award at the 2014 ASBMB annual meeting in San Diego, where she will give a presentation. The presentation will take place at 8:30 a.m. Monday, April 28, in Room 6A of the San Diego Convention Center.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Anna Shipman
Anna Shipman

Anna Shipman received her B.S. in biology–biotechnology from Missouri Western State University and was a Ph.D. student in the School of Biological Sciences at the University of Missouri–Kansas City when she wrote this article.
 

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

ASBMB delegates leave their mark on policymaking
Feature

ASBMB delegates leave their mark on policymaking

Dec. 1, 2022

Advocacy Training Program participants use their new skills to improve their institutional environments, create new programs, draft policy recommendations, perform targeted outreach and more.

2022 Sewer scholarship winners announced
Society News

2022 Sewer scholarship winners announced

Nov. 28, 2022

The $2,000 award goes to undergraduates who demonstrate an interest in the fields of biochemistry and molecular biology and enhance the diversity of science.

Brought to you (mostly) by and for women
Annual Meeting

Brought to you (mostly) by and for women

Nov. 23, 2022

The ASBMB’s Women in Biochemistry and Molecular Biology Committee has big plans for Discover BMB 2023.

Dedicated to sharing science
Student Chapters

Dedicated to sharing science

Nov. 21, 2022

Introduced to scientific research through her Tufts University ASBMB Student Chapter, Lema Abuoqab works to make sure other students can have the same experience.

Tolbert named HHMI VP; new phase for Hannun
Member News

Tolbert named HHMI VP; new phase for Hannun

Nov. 21, 2022

Awards, promotions, milestones and more. Find out what's going on in the lives of ASBMB members.

What’s in the structural vaccine designer’s toolbox?
Interview

What’s in the structural vaccine designer’s toolbox?

Nov. 17, 2022

Structural biologist Jason McLellan, a researcher at UT Austin, has been recognized widely for his work on vaccine development. We asked him about the nuts and bolts of engineering the best antigen.